Physician profile
Blake M Troiani
NPI 1194010157
$1,394.85
in general payments reported to CMS, 2019-2025
17 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $103 · 2021: $145 · 2022: $219 · 2023: $114 · 2024: $269 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501 · Education: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.71 |
| Education | $122.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $461.10 | 2020-2025 | Skyrizi |
| Janssen Biotech, INC. | $194.72 | 2019 | |
| Pfizer INC. | $157.11 | 2019-2024 | |
| Galderma Laboratories, L.P. | $111.49 | 2019-2025 | Aklief, Nemluvio |
| Leo Pharma INC. | $93.06 | 2025 | Adbry, Anzupgo |
| Amgen INC. | $67.82 | 2020 | |
| Sun Pharmaceutical Industries INC. | $46.10 | 2021-2025 | |
| Smith+Nephew, INC. | $40.65 | 2024 | Grafix |
| Encore Dermatology INC. | $37.77 | 2019 | |
| Strata Skin Sciences, INC. | $32.24 | 2022 | |
| Ucb, INC. | $30.76 | 2021 | |
| Incyte Corporation | $27.65 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.81 | 2024 | Spevigo |
| Lilly USA, LLC | $21.56 | 2024 | Taltz |
| Arcutis Biotherapeutics, INC. | $20.76 | 2025 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.15 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Troiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.